Charles McDermott is the founder of Primmune Therapeutics. Primmune Therapeutics has raised $23M, latest Series B $23M (2026). Biotech · San Diego, CA.
Charles McDermott is the founder of Primmune Therapeutics. Primmune Therapeutics operates in Biotech and is based in San Diego, CA. Primmune Therapeutics has raised $23M, latest Series B $23M (2026). Backers on record include Srinivas Akkaraju, Samsara BioCapital.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in San Diego — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library